Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bile salt manipulation for ileal Crohn's disease (atorvastatin + colesevelam)
2009-010163-16Phase 2Terminated
- Sponsor
- University College London
- Start
- Aug 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atorvastatin and colesevelam in Crohn's disease, sponsored by University College London. Primary endpoint: Clinical response at week 6. Started Aug 2009; status: terminated.
02
Drugs
atorvastatincolesevelam
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2009-010163-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010163-16.